C4 Therapeutics Inc (CCCC) Ownership

$2.48

$0.04 (1.64%)
Last update: 09:05 AM EST
Day's range
$2.32
Day's range
$2.55

C4 Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
SQUADRON CAPITAL MANAGEMENT LLC 11/16/2026 9.32 M $31.03 M   29.43% 7.13%
MORGAN STANLEY 11/13/2026 8.87 M $29.55 M   0.06% 6.79%
RA CAPITAL MANAGEMENT, L.P. 11/16/2026 8.19 M $27.29 M   2.43% 6.27%
BLACKROCK, INC. 11/13/2026 8.18 M $27.24 M   3.59% 6.26%
LYNX1 CAPITAL MANAGEMENT LP 11/16/2026 7.53 M $25.08 M   2.79% 5.76%
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC 11/16/2026 7.17 M $23.88 M   0.00% 5.49%
CITADEL ADVISORS LLC 11/16/2026 5.01 M $16.67 M   19.57% 3.83%
JPMORGAN CHASE & CO 11/12/2026 4.70 M $14.70 M   -1.06% 3.59%
GOLDMAN SACHS GROUP INC 11/16/2026 4.68 M $15.60 M   32.64% 3.58%
VANGUARD CAPITAL MANAGEMENT LLC 11/13/2026 4.58 M $15.26 M   3.71% 3.51%
BOXER CAPITAL MANAGEMENT, LLC 11/16/2026 4.15 M $13.82 M   100.00% 3.18%
TWO SIGMA INVESTMENTS, LP 11/16/2026 3.75 M $12.48 M   7.98% 2.87%
SILVERARC CAPITAL MANAGEMENT, LLC 11/12/2026 3.45 M $11.50 M   13.94% 2.64%
SOLEUS CAPITAL MANAGEMENT, L.P. 11/16/2026 3.36 M $11.18 M   -0.59% 2.57%
STEMPOINT CAPITAL LP 11/16/2026 3.29 M $10.97 M   528.93% 2.52%
BANK OF AMERICA CORP /DE/ 11/16/2026 2.89 M $9.63 M   8.82% 2.21%
CANDRIAM S.C.A. 11/03/2026 2.76 M $9.23 M   53.61% 2.11%
GEODE CAPITAL MANAGEMENT, LLC 11/06/2026 2.70 M $8.99 M   7.03% 2.07%
QUBE RESEARCH & TECHNOLOGIES LTD 11/13/2026 2.40 M $7.98 M   546.89% 1.83%
ADAR1 CAPITAL MANAGEMENT, LLC 11/16/2026 2.23 M $7.44 M   664.79% 1.71%
STATE STREET CORP 11/12/2026 2.22 M $7.39 M   4.87% 1.70%
D. E. SHAW & CO., INC. 11/16/2026 2.16 M $7.20 M   24.19% 1.65%
IKARIAN CAPITAL, LLC 11/16/2026 1.93 M $6.44 M   -20.55% 1.48%
ACADIAN ASSET MANAGEMENT LLC 11/09/2026 1.79 M $5.95 M   -1.04% 1.37%
DIMENSIONAL FUND ADVISORS LP 11/04/2026 1.38 M $4.61 M   16.53% 1.06%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/16/2026 1.23 M $4.11 M   58.08% 0.94%
RENAISSANCE TECHNOLOGIES LLC 11/12/2026 1.21 M $4.03 M   1.64% 0.93%
FMR LLC 11/10/2026 1.18 M $3.92 M   31.50% 0.90%
NORTHERN TRUST CORP 11/16/2026 1.16 M $3.85 M   -0.27% 0.89%
VANGUARD PORTFOLIO MANAGEMENT LLC 11/13/2026 1.09 M $3.64 M   60.89% 0.84%
ATOM INVESTORS LP 11/16/2026 911.53 K $3.04 M   150.18% 0.70%
HIGHVISTA STRATEGIES LLC 11/13/2026 873.28 K $2.91 M   -35.22% 0.67%
MARSHALL WACE, LLP 11/13/2026 855.81 K $2.85 M   277.00% 0.65%
AQR CAPITAL MANAGEMENT LLC 11/16/2026 767.99 K $2.56 M   100.00% 0.59%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/16/2026 737.00 K $2.45 M   184.23% 0.56%
VANGUARD FIDUCIARY TRUST CO 11/13/2026 721.74 K $2.40 M   18.48% 0.55%
PANAGORA ASSET MANAGEMENT INC 11/12/2026 690.69 K $2.30 M   160.69% 0.53%
NUVEEN, LLC 11/10/2026 591.83 K $1.97 M   22.28% 0.45%
BOOTHBAY FUND MANAGEMENT, LLC 11/16/2026 585.01 K $1.95 M   -20.55% 0.45%
PLATINUM INVESTMENT MANAGEMENT LTD 11/16/2026 577.53 K $1.92 M   50.10% 0.44%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 11/10/2026 546.35 K $1.82 M   81.67% 0.42%
ROCKEFELLER CAPITAL MANAGEMENT L.P. 11/13/2026 517.59 K $1.72 M   4.39% 0.40%
SQUAREPOINT OPS LLC 11/09/2026 516.55 K $1.72 M   202.37% 0.40%
IKARIAN CAPITAL, LLC 11/16/2026 500.00 K $1.67 M   100.00% 0.38%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/16/2026 494.97 K $1.65 M   -71.43% 0.38%
SCHRODER INVESTMENT MANAGEMENT GROUP 11/16/2026 451.93 K $1.41 M   100.00% 0.35%
SQUADRON CAPITAL MANAGEMENT LLC 11/16/2026 400.00 K $1.33 M   0.00% 0.31%
WELLS FARGO & COMPANY/MN 11/16/2026 396.27 K $1.32 M   -12.47% 0.30%
WELLINGTON MANAGEMENT GROUP LLP 11/16/2026 367.91 K $1.23 M   61.53% 0.28%
POINT72 ASSET MANAGEMENT, L.P. 11/16/2026 340.42 K $1.13 M   95.68% 0.26%

C4 Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 185 institutional investors and hedge funds held shares of C4 Therapeutics Inc. The most heavily invested institutionals were:

Squadron Capital Management LLC: 9.32 M

MORGAN STANLEY: 8.87 M

RA CAPITAL MANAGEMENT, L.P.: 8.19 M

BlackRock, Inc.: 8.18 M

Lynx1 Capital Management LP: 7.53 M

Bain Capital Life Sciences Investors, LLC: 7.17 M

101.10% of C4 Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 143.38 M shares in the last 24 months. This purchase volume represents approximately $355.59 M in transactions.